MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential by Fangying Dong, Jing Zhou, Yijie Wu, Zhaofeng Gao, Weiwei Li, Zhengwei Song

Subjects: “…pancreatic cancer…”
Get full text

Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapy by Wenjing Bai, Jinxin Xu, Wenbin Gu, Danyang Wang, Ying Cui, Weidong Rong, Xiaoan Du, Xiaoxia Li, Cuicui Xia, Qingqing Gan, Guantao He, Huahui Guo, Jinfeng Deng, Yuqiong Wu, Ray-Whay Chiu Yen, Srinivasan Yegnasubramanian, Scott B. Rothbart, Cheng Luo, Linping Wu, Jinsong Liu, Stephen B. Baylin, Xiangqian Kong

“…For translating these findings to cancer therapy, we use a lipid nanoparticle (LNP)-mediated mRNA delivery approach in which the short mSTELLA, but not hSTELLA regions are required to reverse cancer-specific DNA hypermethylation and impair colorectal cancer tumorigenicity.…”
Get full text

From tedious to targeted: Optimizing oral cancer research with Consensus AI by Ajinkya M. Pawar, Rajiv Desai, Bhagyashree Thakur

“…Barriers which include subjective biases, overabundance of data, and budget limitations impede oral cancer research. Conventional techniques consume an extensive amount of time, are biased, and have limitations. …”
Get full text

Biliary drainage in pancreatic cancer with duodenal invasion: which route is the best? by Tanyaporn Chantarojanasiri, Thawee Ratanachu-Ek

Get full text

Intratumor microbiome-derived butyrate promotes chemo-resistance in colorectal cancer by Linsheng Xu, Linsheng Xu, Bingde Hu, Jingli He, Xin Fu, Na Liu

Subjects: “…colorectal cancer…”
Get full text

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines by Luis E. Fernandez, Mariano R. Gabri, Marcelo D. Guthmann, Roberto E. Gomez, Silvia Gold, Leonardo Fainboim, Daniel E. Gomez, Daniel F. Alonso

“…Active specific immunotherapy is a promising field in cancer research. N-glycolyl (NGc) gangliosides, and particularly NGcGM3, have received attention as a privileged target for cancer therapy. …”
Get full text

A Neglected Point: Frailty in Older Adults with Differentiated Thyroid Cancer by Meric Coskun, Esra Cataltepe, Hacer Dogan Varan, Eda Ceker, Yasemin Bektas, Yasemin Kuscu, Mehmet Muhittin Yalcin, Mujde Akturk, Fusun Balos Toruner, Mehmet Ayhan Karakoc, Alev Eroglu Altinova

Subjects: “…differentiated thyroid cancer…”
Get full text

Quercetin, a natural antioxidant compound for the treatment of oral cancer therapy by Sureshkumar Selvaraj, Baskar Venkidasamy

Subjects: Get full text

Is there still a place for open surgery in the treatment strategy of rectal cancer? by Andrzej Kawiński, Łukasz Dziki, Radzisław Trzciński, Adam Dziki, Michał Mik

Subjects: “…rectal cancer…”
Get full text

Aggressive Multimodal Approach for Anaplastic Thyroid Cancer and Long-Term Survival by Nasir Hussain, Usman Mustafa, Su Hyeon Jung, Alan D. Gilman

“…Anaplastic thyroid cancer (ATC) comprises 1-2% of all thyroid cancers and is one of the most aggressive cancers with a median survival rate of around four months. …”
Get full text

Human blood metabolites and gastric cancer: a Mendelian randomization analysis by Chao Zhang, Dao Lai Huang, Kun Zhou, Jin Tao Cai, Dang Liu, Ming Hao Tan, Guan Yu Zhu, Xiang Hua Wu

Subjects: Get full text

Prospects for the use of <i>Bacillus anthracis</i> toxin in cancer therapy by A. P. Rodionov, S. V. Ivanova, E. A. Artemeva, L. A. Melnikova

Subjects: Get full text

Towards unbiased skin cancer classification using deep feature fusion by Ali Atshan Abdulredah, Mohammed A. Fadhel, Laith Alzubaidi, Ye Duan, Monji Kherallah, Faiza Charfi

Subjects: Get full text

Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept by Guido Giordano, Antonio Febbraro, Michele Venditti, Serena Campidoglio, Nunzio Olivieri, Katia Raieta, Pietro Parcesepe, Giusy Carmen Imbriani, Andrea Remo, Massimo Pancione

“…In the last decades, we have progressively observed an improvement in therapeutic options for metastatic colorectal cancer (mCRC) treatment with a progressive prolongation of survival. mCRC prognosis still remains poor with low percentage of 5-year survival. …”
Get full text

Adaptive Treatment of Metastatic Prostate Cancer Using Generative Artificial Intelligence by Youcef Derbal

“…Despite the expanding therapeutic options available to cancer patients, therapeutic resistance, disease recurrence, and metastasis persist as hallmark challenges in the treatment of cancer. …”
Get full text

Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients by Zihan Zhu, Rui Geng, Yixin Zhang, Jinhui Liu, Jianling Bai

“…The exosome is of vital importance throughout the entire progression of cancer. Because of the lack of effective biomarkers in ovarian cancer (OV), we intend to investigate the connection between exosomes and tumor immune microenvironment to verify that exosome-related genes (ERGs) can precisely forecast the prognosis of OV patients. …”
Get full text

Identification of ERBB Pathway-Activated Cells in Triple-Negative Breast Cancer by Soo Young Cho

“…The molecular characterization of intratumor heterogeneity in breast cancer is a significant challenge for effective treatment. …”
Get full text

Rapid Progression to Death of Critically ill Cancer Patients with COVID-19 by Ariel Sosa Remón, Ana Esperanza Jerez Álvarez, Andrés Soto García

Get full text

Age Dependent Switching Role of Cyclin D1 in Breast Cancer by Carmela Rinaldi, Natalia Maria Malara, Rosalia D’Angelo, Antonina Sidoti, Attilio Leotta, Santo Lio, Basilio Caparello, Alessia Ruggeri, Vincenzo Mollace, Aldo Amato

“…Background: Cyclin D1 gene (CCND1) plays pivotal roles in the development of several human cancers, including breast cancer, functioning as an oncogene. …”
Get full text

Exploring efferocytosis in oral cancer: Implications for treatment strategies and prognostic insights by Ramadurai Murugan, Monisha Prasad

Get full text